Using cell protein to detect bile duct cancer from ERCP samples
Part of Cancer clinical trials.
This study looks at a protein called plectin on the surface of cells to see if it can help diagnose bile duct cancer using samples taken during a routine ERCP procedure. If you already need an ERCP for a narrowed or blocked bile duct, this may help improve cancer detection.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a narrowing or blockage in your bile duct that shows up on imaging scans.
- You are already scheduled to have an ERCP as part of your regular medical care.
- You are 18 years old or older.
- You are able to give your own consent to participate.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is testing if a new protein-based lab test can better identify bile duct cancer from stored tissue samples. It's looking for people who had a bile duct sample taken but don't yet have a clear cancer diagnosis.
This trial tests whether a sample of bile (a fluid produced by your liver) can help doctors diagnose bile duct cancer more accurately. If you have a narrowing in your bile duct and need a procedure to take a tissue sample, you may be able to participate.
This trial uses a bile sample to help diagnose the cause of a bile duct stricture (a narrowing) that was not clearly identified by standard tests. It may help patients avoid more invasive procedures.
This study is testing a new way to use a simple blood test to help diagnose cholangiocarcinoma (bile duct cancer) earlier and more accurately. It is for people whose tumors can be surgically removed and who have not had prior cancer treatment.
This study tests a tiny camera and ultrasound probe that can be passed through a scope to look inside the bile duct. It may help doctors better diagnose and treat bile duct narrowings that do not cause jaundice.
This study looks at how well a special ultrasound-guided biopsy checks lymph nodes before surgery or liver transplant for bile duct cancer. The goal is to see if this method accurately shows whether the cancer has spread to nearby lymph nodes.
Hear when a new Cholangiocarcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.